Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s13046-016-0487-8.

Title:
Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer | Journal of Experimental & Clinical Cancer Research
Description:
Background Gastric cancer is one of the major causes of cancer-related mortality worldwide. Most of patients presenting with inoperable gastric cancers rely on systemic chemotherapy for prolongation of survival. Doxorubicin (DOX) is one of the important agents against gastric cancer. Acquired DOX-resistance severely impedes the chemotherapeutic effect, invariably leading to poor prognosis. Resveratrol (RES) as a kind of phytoalexin has demonstrated anti-tumor functions in breast cancer and myeloid leukemia, but its function and mechanism are still unknown in gastric cancer treatment. Methods CCK8 assay was used to detect the cytotoxicity of DOX and RES to gastric cancer cells. DOX-resistant subclone cell line (SGC7901/DOX) was derived from SGC7901 cells exposed to stepwise increasing concentrations of DOX treatment. We measured the migratory capabilities of SGC7901/DOX cells by Cell scratch test and Transwell assay. SGC7901/DOX cells were treated with DOX, RES, neither or both. Then we analyzed cell survival by CCK8 assay, colony formation by Colony-forming assay, cell apoptosis by Annexin-V-FITC and PI dual staining assay and cell migration by Cell scratch test and Transwell assay. Western blotting was conducted to detect the protein expressions of PTEN/Akt signaling pathway and EMT-related markers. Immunofluorescence was performed to confirm the EMT-related markers expressions. The xenograft model was used to assess the effect of DOX and RES in vivo. The key molecules associated with proliferation, apoptosis and EMT were evaluated by immunohistochemistry in tumor specimens. Results SGC7901/DOX cells acquired drug resistance and enhancive migratory capability. RES enabled SGC7901/DOX cells to regain DOX sensitivity, mitigated the aggressive biological features, promoted cell apoptosis in vitro and inhibited tumor growth in vivo. Mechanistic studies revealed that SGC7901/DOX cells underwent epithelial-mesenchymal transition (EMT) which was induced by Akt activation, and through activating PTEN, RES inhibited the Akt pathway, and then achieved the reversion of EMT. Conclusion RES serves as a novel solution to reverse the DOX-resistance of gastric cancer via preventing EMT by modulating PTEN/Akt signaling pathway. DOX-RES combined treatment provides a promising future for gastric cancer patients to postpone drug resistance and prolong survival.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure if the website is profiting.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

cells, res, dox, cancer, cell, sgcdox, mgl, treatment, gastric, pubmed, article, emt, google, scholar, fig, signaling, assay, vimentin, sgc, cas, resistance, migration, akt, expression, effect, pathway, tumor, survival, apoptosis, pten, treated, combined, caspase, doxorubicin, concentration, βcatenin, data, resveratrol, chemotherapy, drug, group, analysis, ecadherin, image, effects, medium, transition, ptenakt, results, study,

Topics {✒️}

akt/gsk-3beta/beta-catenin signaling akt/gsk-3β/β-catenin pathway doxorubicin-induced epithelial-mesenchymal transition emt-mediated therapeutic resistance 5 μl annexin-v-fitc droplet-based microtumor model trans-membrane sgc7901/dox cells inhibiting epithelial-mesenchymal transition tgf-beta-induced epithelial potent anti-tumor activity pi3k/akt signaling pathway e-cadherin/β-catenin complex article download pdf gas6/axl axis contributes sgc7901/dox cell line cancer-related mortality worldwide pten/akt signaling pathway long-term dox treatment trans-membrane migrating cells annexin-v-fitc β-catenin nuclear tranlocation dox-resistant sgc7901/dox semi-quantitative image analysis emt lineage-tracing system assess cell-ecm interactions illustrates dox-induced emt showed chemo-resistance owing epithelial–mesenchymal transition pten/akt signaling expression demonstrated anti-tumor functions sgc7901/dox cell migration suppress dox-induced emt exhibit chemo-preventive effect prospective clinical trials sgc7901/dox cell survival canonical signaling pathways measeuring emt-related proteins sgc7901/dox cell colonies gold therapy regimen emt-related markers expressions dox-free culture medium multiple drug resistance sgc7901/dox cells reached reverses multidrug-resistance mesenchymal cell markers sgc7901/dox cells enhanced sgc7901/dox cells displayed cell-cell adhesion full size image specific antigen-binding sites

Questions {❓}

  • Adenocarcinoma of the stomach: are we making progress?
  • Resveratrol supplementation: where are we now and where should we go?
  • Targeting the PI3K/Akt signaling pathway in gastric carcinoma: a reality for personalized medicine?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer
         description:Gastric cancer is one of the major causes of cancer-related mortality worldwide. Most of patients presenting with inoperable gastric cancers rely on systemic chemotherapy for prolongation of survival. Doxorubicin (DOX) is one of the important agents against gastric cancer. Acquired DOX-resistance severely impedes the chemotherapeutic effect, invariably leading to poor prognosis. Resveratrol (RES) as a kind of phytoalexin has demonstrated anti-tumor functions in breast cancer and myeloid leukemia, but its function and mechanism are still unknown in gastric cancer treatment. CCK8 assay was used to detect the cytotoxicity of DOX and RES to gastric cancer cells. DOX-resistant subclone cell line (SGC7901/DOX) was derived from SGC7901 cells exposed to stepwise increasing concentrations of DOX treatment. We measured the migratory capabilities of SGC7901/DOX cells by Cell scratch test and Transwell assay. SGC7901/DOX cells were treated with DOX, RES, neither or both. Then we analyzed cell survival by CCK8 assay, colony formation by Colony-forming assay, cell apoptosis by Annexin-V-FITC and PI dual staining assay and cell migration by Cell scratch test and Transwell assay. Western blotting was conducted to detect the protein expressions of PTEN/Akt signaling pathway and EMT-related markers. Immunofluorescence was performed to confirm the EMT-related markers expressions. The xenograft model was used to assess the effect of DOX and RES in vivo. The key molecules associated with proliferation, apoptosis and EMT were evaluated by immunohistochemistry in tumor specimens. SGC7901/DOX cells acquired drug resistance and enhancive migratory capability. RES enabled SGC7901/DOX cells to regain DOX sensitivity, mitigated the aggressive biological features, promoted cell apoptosis in vitro and inhibited tumor growth in vivo. Mechanistic studies revealed that SGC7901/DOX cells underwent epithelial-mesenchymal transition (EMT) which was induced by Akt activation, and through activating PTEN, RES inhibited the Akt pathway, and then achieved the reversion of EMT. RES serves as a novel solution to reverse the DOX-resistance of gastric cancer via preventing EMT by modulating PTEN/Akt signaling pathway. DOX-RES combined treatment provides a promising future for gastric cancer patients to postpone drug resistance and prolong survival.
         datePublished:2017-01-26T00:00:00Z
         dateModified:2023-01-17T00:00:00Z
         pageStart:1
         pageEnd:14
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s13046-016-0487-8
         keywords:
            Resveratrol
            Doxorubicin
            Drug resistance
            EMT
            PTEN/Akt
            Cancer Research
            Immunology
            Apoptosis
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig6_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig7_HTML.gif
         isPartOf:
            name:Journal of Experimental & Clinical Cancer Research
            issn:
               1756-9966
            volumeNumber:36
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Jiahui Xu
               affiliation:
                     name:Southern Medical University
                     address:
                        name:Nanfang Hospital/First Clinical Medical School, Southern Medical University, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Deying Liu
               affiliation:
                     name:Southern Medical University
                     address:
                        name:Nanfang Hospital/First Clinical Medical School, Southern Medical University, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Huilin Niu
               affiliation:
                     name:Southern Medical University
                     address:
                        name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Guifang Zhu
               affiliation:
                     name:Southern Medical University
                     address:
                        name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yangwei Xu
               affiliation:
                     name:Southern Medical University
                     address:
                        name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Danli Ye
               affiliation:
                     name:Southern Medical University
                     address:
                        name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jian Li
               affiliation:
                     name:Southern Medical University
                     address:
                        name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Qingling Zhang
               affiliation:
                     name:Southern Medical University
                     address:
                        name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
                        type:PostalAddress
                     type:Organization
                     name:Southern Medical University
                     address:
                        name:Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer
      description:Gastric cancer is one of the major causes of cancer-related mortality worldwide. Most of patients presenting with inoperable gastric cancers rely on systemic chemotherapy for prolongation of survival. Doxorubicin (DOX) is one of the important agents against gastric cancer. Acquired DOX-resistance severely impedes the chemotherapeutic effect, invariably leading to poor prognosis. Resveratrol (RES) as a kind of phytoalexin has demonstrated anti-tumor functions in breast cancer and myeloid leukemia, but its function and mechanism are still unknown in gastric cancer treatment. CCK8 assay was used to detect the cytotoxicity of DOX and RES to gastric cancer cells. DOX-resistant subclone cell line (SGC7901/DOX) was derived from SGC7901 cells exposed to stepwise increasing concentrations of DOX treatment. We measured the migratory capabilities of SGC7901/DOX cells by Cell scratch test and Transwell assay. SGC7901/DOX cells were treated with DOX, RES, neither or both. Then we analyzed cell survival by CCK8 assay, colony formation by Colony-forming assay, cell apoptosis by Annexin-V-FITC and PI dual staining assay and cell migration by Cell scratch test and Transwell assay. Western blotting was conducted to detect the protein expressions of PTEN/Akt signaling pathway and EMT-related markers. Immunofluorescence was performed to confirm the EMT-related markers expressions. The xenograft model was used to assess the effect of DOX and RES in vivo. The key molecules associated with proliferation, apoptosis and EMT were evaluated by immunohistochemistry in tumor specimens. SGC7901/DOX cells acquired drug resistance and enhancive migratory capability. RES enabled SGC7901/DOX cells to regain DOX sensitivity, mitigated the aggressive biological features, promoted cell apoptosis in vitro and inhibited tumor growth in vivo. Mechanistic studies revealed that SGC7901/DOX cells underwent epithelial-mesenchymal transition (EMT) which was induced by Akt activation, and through activating PTEN, RES inhibited the Akt pathway, and then achieved the reversion of EMT. RES serves as a novel solution to reverse the DOX-resistance of gastric cancer via preventing EMT by modulating PTEN/Akt signaling pathway. DOX-RES combined treatment provides a promising future for gastric cancer patients to postpone drug resistance and prolong survival.
      datePublished:2017-01-26T00:00:00Z
      dateModified:2023-01-17T00:00:00Z
      pageStart:1
      pageEnd:14
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s13046-016-0487-8
      keywords:
         Resveratrol
         Doxorubicin
         Drug resistance
         EMT
         PTEN/Akt
         Cancer Research
         Immunology
         Apoptosis
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig6_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-016-0487-8/MediaObjects/13046_2016_487_Fig7_HTML.gif
      isPartOf:
         name:Journal of Experimental & Clinical Cancer Research
         issn:
            1756-9966
         volumeNumber:36
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Jiahui Xu
            affiliation:
                  name:Southern Medical University
                  address:
                     name:Nanfang Hospital/First Clinical Medical School, Southern Medical University, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Deying Liu
            affiliation:
                  name:Southern Medical University
                  address:
                     name:Nanfang Hospital/First Clinical Medical School, Southern Medical University, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Huilin Niu
            affiliation:
                  name:Southern Medical University
                  address:
                     name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Guifang Zhu
            affiliation:
                  name:Southern Medical University
                  address:
                     name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yangwei Xu
            affiliation:
                  name:Southern Medical University
                  address:
                     name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Danli Ye
            affiliation:
                  name:Southern Medical University
                  address:
                     name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jian Li
            affiliation:
                  name:Southern Medical University
                  address:
                     name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Qingling Zhang
            affiliation:
                  name:Southern Medical University
                  address:
                     name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
                     type:PostalAddress
                  type:Organization
                  name:Southern Medical University
                  address:
                     name:Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Journal of Experimental & Clinical Cancer Research
      issn:
         1756-9966
      volumeNumber:36
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Southern Medical University
      address:
         name:Nanfang Hospital/First Clinical Medical School, Southern Medical University, Guangzhou, China
         type:PostalAddress
      name:Southern Medical University
      address:
         name:Nanfang Hospital/First Clinical Medical School, Southern Medical University, Guangzhou, China
         type:PostalAddress
      name:Southern Medical University
      address:
         name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
         type:PostalAddress
      name:Southern Medical University
      address:
         name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
         type:PostalAddress
      name:Southern Medical University
      address:
         name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
         type:PostalAddress
      name:Southern Medical University
      address:
         name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
         type:PostalAddress
      name:Southern Medical University
      address:
         name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
         type:PostalAddress
      name:Southern Medical University
      address:
         name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
         type:PostalAddress
      name:Southern Medical University
      address:
         name:Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Jiahui Xu
      affiliation:
            name:Southern Medical University
            address:
               name:Nanfang Hospital/First Clinical Medical School, Southern Medical University, Guangzhou, China
               type:PostalAddress
            type:Organization
      name:Deying Liu
      affiliation:
            name:Southern Medical University
            address:
               name:Nanfang Hospital/First Clinical Medical School, Southern Medical University, Guangzhou, China
               type:PostalAddress
            type:Organization
      name:Huilin Niu
      affiliation:
            name:Southern Medical University
            address:
               name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
               type:PostalAddress
            type:Organization
      name:Guifang Zhu
      affiliation:
            name:Southern Medical University
            address:
               name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
               type:PostalAddress
            type:Organization
      name:Yangwei Xu
      affiliation:
            name:Southern Medical University
            address:
               name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
               type:PostalAddress
            type:Organization
      name:Danli Ye
      affiliation:
            name:Southern Medical University
            address:
               name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
               type:PostalAddress
            type:Organization
      name:Jian Li
      affiliation:
            name:Southern Medical University
            address:
               name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
               type:PostalAddress
            type:Organization
      name:Qingling Zhang
      affiliation:
            name:Southern Medical University
            address:
               name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
               type:PostalAddress
            type:Organization
            name:Southern Medical University
            address:
               name:Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Nanfang Hospital/First Clinical Medical School, Southern Medical University, Guangzhou, China
      name:Nanfang Hospital/First Clinical Medical School, Southern Medical University, Guangzhou, China
      name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
      name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
      name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
      name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
      name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
      name:Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
      name:Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China

External Links {🔗}(158)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

5.14s.